Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 613

1.

Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group.

Yoo C, Im HS, Kim KP, Oh DY, Lee KH, Chon HJ, Kim JH, Kang M, Kim I, Lee GJ, Oh SY, Choi Y, Choi HJ, Kim ST, Park JO, Ryoo BY.

Ther Adv Med Oncol. 2019 Aug 23;11:1758835919871126. doi: 10.1177/1758835919871126. eCollection 2019.

2.

Cancer Panel Assay for Precision Oncology Clinic: Results from a 1-Year Study.

Kwon D, Kim B, Shin HC, Kim EJ, Ha SY, Jang KT, Kim ST, Lee J, Kang WK, Park JO, Kim KM.

Transl Oncol. 2019 Aug 20;12(11):1488-1495. doi: 10.1016/j.tranon.2019.07.017. [Epub ahead of print]

3.

Neutralizing antibody to FGFR2 can act as a selective biomarker and potential therapeutic agent for gastric cancer with FGFR2 amplification.

Kim ST, Lee IK, Rom E, Sirkis R, Park SH, Park JO, Park YS, Lim HY, Kang WK, Kim KM, Yayon A, Lee J.

Am J Transl Res. 2019 Jul 15;11(7):4508-4515. eCollection 2019.

4.

Tumor genomic profiling guides metastatic gastric cancer patients to targeted treatment: The VIKTORY Umbrella Trial.

Lee J, Kim ST, Kim K, Lee H, Kozarewa I, Mortimer PG, Odegaard JI, Harrington EA, Lee J, Lee T, Oh SY, Kang JH, Kim JH, Kim Y, Ji JH, Kim YS, Lee KE, Kim J, Sohn TS, An JY, Choi MG, Lee JH, Bae JM, Kim S, Kim JJ, Min YW, Min BH, Kim NKD, Luke S, Kim YH, Hong JY, Park SH, Park JO, Park YS, Lim HY, Talasaz A, Hollingsworth SJ, Kim KM, Kang WK.

Cancer Discov. 2019 Jul 17. pii: CD-19-0442. doi: 10.1158/2159-8290.CD-19-0442. [Epub ahead of print]

PMID:
31315834
5.

A wireless tattooing capsule endoscope using external electromagnetic actuation and chemical reaction pressure.

Hoang MC, Le VH, Kim J, Choi E, Kang B, Park JO, Kim CS.

PLoS One. 2019 Jul 16;14(7):e0219740. doi: 10.1371/journal.pone.0219740. eCollection 2019.

6.

The impact of primary tumor site on outcomes of treatment with etoposide and cisplatin in grade 3 gastroenteropancreatic neuroendocrine carcinoma.

Yoon SE, Kim JH, Lee SJ, Lee J, Park SH, Park JO, Lim HY, Kang WK, Park YS, Kim ST.

J Cancer. 2019 Jun 2;10(14):3140-3144. doi: 10.7150/jca.30355. eCollection 2019.

7.
8.

LAG3 in Solid Tumors as a Potential Novel Immunotherapy Target.

Lee SJ, Byeon SJ, Lee J, Park SH, Park JO, Park YS, Kang WK, Lim HY, Kim KM, Kim ST.

J Immunother. 2019 Oct;42(8):279-283. doi: 10.1097/CJI.0000000000000283.

PMID:
31219974
9.

Energy budget of Drosophila embryogenesis.

Song Y, Park JO, Tanner L, Nagano Y, Rabinowitz JD, Shvartsman SY.

Curr Biol. 2019 Jun 17;29(12):R566-R567. doi: 10.1016/j.cub.2019.05.025.

PMID:
31211973
10.

The Impact of Primary Tumor Sidedness on the Effect of Regorafenib in Refractory Metastatic Colorectal Cancer.

Yoon SE, Lee SJ, Lee J, Park SH, Park JO, Lim HY, Kang WK, Park YS, Kim ST.

J Cancer. 2019 Mar 3;10(7):1611-1615. doi: 10.7150/jca.29106. eCollection 2019.

11.

A Two-Enzyme Adaptive Unit within Bacterial Folate Metabolism.

Schober AF, Mathis AD, Ingle C, Park JO, Chen L, Rabinowitz JD, Junier I, Rivoire O, Reynolds KA.

Cell Rep. 2019 Jun 11;27(11):3359-3370.e7. doi: 10.1016/j.celrep.2019.05.030.

12.

Indirect Force Control of a Cable-Driven Parallel Robot: Tension Estimation using Artificial Neural Network trained by Force Sensor Measurements.

Piao J, Kim ES, Choi H, Moon CB, Choi E, Park JO, Kim CS.

Sensors (Basel). 2019 Jun 1;19(11). pii: E2520. doi: 10.3390/s19112520.

13.

Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.

Golan T, Hammel P, Reni M, Van Cutsem E, Macarulla T, Hall MJ, Park JO, Hochhauser D, Arnold D, Oh DY, Reinacher-Schick A, Tortora G, Algül H, O'Reilly EM, McGuinness D, Cui KY, Schlienger K, Locker GY, Kindler HL.

N Engl J Med. 2019 Jul 25;381(4):317-327. doi: 10.1056/NEJMoa1903387. Epub 2019 Jun 2.

PMID:
31157963
14.

Transoral endoscopic thyroid surgery in a Korean population.

Park JO, Anuwong A, Kim MR, Sun DI, Kim MS.

Surg Endosc. 2019 Jul;33(7):2104-2113. doi: 10.1007/s00464-018-6481-9. Epub 2019 May 28.

PMID:
31139979
15.

Gasless transoral endoscopic thyroidectomy vestibular approach (gasless TOETVA).

Park JO, Park YJ, Kim MR, Sun DI, Kim MS, Koh YW.

Surg Endosc. 2019 Sep;33(9):3034-3039. doi: 10.1007/s00464-019-06826-7. Epub 2019 May 13.

PMID:
31087173
16.

Risk of Revision Following Total Knee Arthroplasty or High Tibial Osteotomy: A Nationwide Propensity-Score-Matched Study.

Yoon JR, Ko SN, Jung KY, Lee Y, Park JO, Shin YS.

J Bone Joint Surg Am. 2019 May 1;101(9):771-778. doi: 10.2106/JBJS.18.00980.

PMID:
31045664
17.

Transoral endoscopic thyroid surgery using robotic scope holder: Our initial experiences.

Park JO, Kim MR, Park YJ, Kim MS, Sun DI.

J Minim Access Surg. 2019 Apr 24. doi: 10.4103/jmas.JMAS_12_19. [Epub ahead of print]

18.

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial.

Eng C, Kim TW, Bendell J, Argilés G, Tebbutt NC, Di Bartolomeo M, Falcone A, Fakih M, Kozloff M, Segal NH, Sobrero A, Yan Y, Chang I, Uyei A, Roberts L, Ciardiello F; IMblaze370 Investigators.

Lancet Oncol. 2019 Jun;20(6):849-861. doi: 10.1016/S1470-2045(19)30027-0. Epub 2019 Apr 16. Erratum in: Lancet Oncol. 2019 Jun;20(6):e293.

PMID:
31003911
19.

Correction: Rotating hinge knee versus constrained condylar knee in revision total knee arthroplasty: A meta-analysis.

Yoon JR, Cheong JY, Im JT, Park PS, Park JO, Shin YS.

PLoS One. 2019 Apr 18;14(4):e0216004. doi: 10.1371/journal.pone.0216004. eCollection 2019.

20.

Selective colony area method for heterogeneous patient-derived tumor cell lines in anti-cancer drug screening system.

Cho JH, Kim JS, Kim ST, Hong JY, Park JO, Park YS, Nam DH, Lee DW, Lee J.

PLoS One. 2019 Apr 17;14(4):e0215080. doi: 10.1371/journal.pone.0215080. eCollection 2019.

21.

The Feasibility of a Prototype Thyroidoscope for Gasless Transoral Endoscopic Thyroidectomy: A Preclinical Cadaver Study.

Park JO, Wang SG, Park D, Bae IH, Lee JC, Lee BJ, Shin SC.

J Laparoendosc Adv Surg Tech A. 2019 Jul;29(7):953-957. doi: 10.1089/lap.2019.0107. Epub 2019 Apr 16.

PMID:
30990359
22.

Guidelines Insights: Hepatobiliary Cancers, Version 2.2019.

Benson AB, D'Angelica MI, Abbott DE, Abrams TA, Alberts SR, Anaya DA, Anders R, Are C, Brown D, Chang DT, Cloyd J, Covey AM, Hawkins W, Iyer R, Jacob R, Karachristos A, Kelley RK, Kim R, Palta M, Park JO, Sahai V, Schefter T, Sicklick JK, Singh G, Sohal D, Stein S, Tian GG, Vauthey JN, Venook AP, Hammond LJ, Darlow SD.

J Natl Compr Canc Netw. 2019 Apr 1;17(4):302-310. doi: 10.6004/jnccn.2019.0019.

PMID:
30959462
23.

Achievements, Problems, and Future Direction of the Quality Control Program for Special Periodic Health Examination Agencies in Republic of Korea.

Won YL, Ko KS, Park JO, Choi YJ, Lee H, Sung JM, Lee MY.

Saf Health Work. 2019 Mar;10(1):125-129. doi: 10.1016/j.shaw.2018.11.003. Epub 2018 Dec 1.

24.

Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer.

Seo YD, Jiang X, Sullivan KM, Jalikis FG, Smythe KS, Abbasi A, Vignali M, Park JO, Daniel SK, Pollack SM, Kim TS, Yeung R, Crispe IN, Pierce RH, Robins H, Pillarisetty VG.

Clin Cancer Res. 2019 Jul 1;25(13):3934-3945. doi: 10.1158/1078-0432.CCR-19-0081. Epub 2019 Apr 2.

PMID:
30940657
25.

Staged Mosaic Punching Excision of a Kissing Nevus on the Eyelid.

Cho HJ, Lee W, Jeon MK, Park JO, Yang EJ.

Aesthetic Plast Surg. 2019 Jun;43(3):652-657. doi: 10.1007/s00266-019-01362-0. Epub 2019 Apr 1.

PMID:
30937473
26.

Rotating hinge knee versus constrained condylar knee in revision total knee arthroplasty: A meta-analysis.

Yoon JR, Cheong JY, Im JT, Park PS, Park JO, Shin YS.

PLoS One. 2019 Mar 25;14(3):e0214279. doi: 10.1371/journal.pone.0214279. eCollection 2019. Erratum in: PLoS One. 2019 Apr 18;14(4):e0216004.

27.

Preventable Trauma Death Rate after Establishing a National Trauma System in Korea.

Jung K, Kim I, Park SK, Cho H, Park CY, Yun JH, Kim OH, Park JO, Lee KJ, Hong KJ, Yoon HD, Park JM, Kim S, Sung HK, Choi J, Kim Y.

J Korean Med Sci. 2019 Feb 22;34(8):e65. doi: 10.3346/jkms.2019.34.e65. eCollection 2019 Mar 4.

28.

Bridging genomics and phenomics of gastric carcinoma.

Cho J, Ahn S, Son DS, Kim NK, Lee KW, Kim S, Lee J, Park SH, Park JO, Kang WK, An JY, Choi MG, Lee JH, Sohn TS, Bae JM, Kim S, Kim KM.

Int J Cancer. 2019 Nov 1;145(9):2407-2417. doi: 10.1002/ijc.32228. Epub 2019 Mar 18.

PMID:
30801717
29.

Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trial.

Kim ST, Kang JH, Lee J, Lee HW, Oh SY, Jang JS, Lee MA, Sohn BS, Yoon SY, Choi HJ, Hong JH, Kim MJ, Kim S, Park YS, Park JO, Lim HY.

Ann Oncol. 2019 May 1;30(5):788-795. doi: 10.1093/annonc/mdz058.

PMID:
30785198
30.

Multidisciplinary approach for multifocal, bilobar hepatocellular carcinoma: A case report and literature review.

Labadie KP, Schaub SK, Khorsand D, Johnson G, Apisarnthanarax S, Park JO.

World J Hepatol. 2019 Jan 27;11(1):119-126. doi: 10.4254/wjh.v11.i1.119.

31.

Combination of Docetaxel Plus Savolitinib in Refractory Cancer Patients: A Report on Phase I Trial.

Kim ST, Lee S, Park M, Park SH, Park JO, Lim HY, Park YS, Kang WK, Gangolli EA, Shin H, Kim KM, Hollingsworth SJ, Mortimer PGS, Lee J.

Transl Oncol. 2019 Apr;12(4):597-601. doi: 10.1016/j.tranon.2018.12.009. Epub 2019 Jan 26.

32.

The use of regorafenib for patients with refractory metastatic colorectal cancer in clinical practice.

Yoon SE, Lee SJ, Lee J, Park SH, Park JO, Lim HY, Kang WK, Park YS, Kim ST.

Onco Targets Ther. 2018 Dec 24;12:225-231. doi: 10.2147/OTT.S187621. eCollection 2019.

33.

Production of bio-oil from fast pyrolysis of biomass using a pilot-scale circulating fluidized bed reactor and its characterization.

Park JY, Kim JK, Oh CH, Park JW, Kwon EE.

J Environ Manage. 2019 Mar 15;234:138-144. doi: 10.1016/j.jenvman.2018.12.104. Epub 2019 Jan 4.

PMID:
30616185
34.

Curvature-Induced Twist in Homeotropic Nematic Tori.

Ellis PW, Nayani K, McInerney JP, Rocklin DZ, Park JO, Srinivasarao M, Matsumoto EA, Fernandez-Nieves A.

Phys Rev Lett. 2018 Dec 14;121(24):247803. doi: 10.1103/PhysRevLett.121.247803.

PMID:
30608771
35.

Adjuvant Chemotherapy with or without Concurrent Radiotherapy for Patients with Stage IB Gastric Cancer: a Subgroup Analysis of the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Phase III Trial.

Kim Y, Kim KM, Choi MG, Lee JH, Sohn TS, Bae JM, Kim S, Lee SJ, Kim ST, Lee J, Park JO, Park YS, Lim HY, Kang WK, Park SH.

J Gastric Cancer. 2018 Dec;18(4):348-355. doi: 10.5230/jgc.2018.18.e34. Epub 2018 Nov 16.

36.

Standardization of perioperative care facilitates safe discharge by postoperative day five after pancreaticoduodenectomy.

Daniel SK, Thornblade LW, Mann GN, Park JO, Pillarisetty VG.

PLoS One. 2018 Dec 28;13(12):e0209608. doi: 10.1371/journal.pone.0209608. eCollection 2018.

37.

A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-Line Chemotherapy in Metastatic Colorectal Cancer Patients.

Kim Y, Kim TW, Han SW, Ahn JB, Kim ST, Lee J, Park JO, Park YS, Lim HY, Kang WK.

Cancer Res Treat. 2019 Jul;51(3):1128-1134. doi: 10.4143/crt.2018.379. Epub 2018 Nov 21.

38.

TAS-118 (S-1 plus leucovorin) versus S-1 in patients with gemcitabine-refractory advanced pancreatic cancer: a randomised, open-label, phase 3 study (GRAPE trial).

Ioka T, Ueno M, Ueno H, Park JO, Chang HM, Sasahira N, Kanai M, Chung IJ, Ikeda M, Nakamori S, Mizuno N, Omuro Y, Yamaguchi T, Hara H, Sugimori K, Furuse J, Maguchi H, Furukawa M, Fukuzawa K, Kim JS, Yukisawa S, Takeuchi M, Okusaka T, Boku N, Hyodo I.

Eur J Cancer. 2019 Jan;106:78-88. doi: 10.1016/j.ejca.2018.10.004. Epub 2018 Nov 22.

39.

A Guide-Wired Helical Microrobot for Mechanical Thrombectomy: A Feasibility Study.

Nguyen KT, Go G, Choi E, Kang B, Park JO, Kim CS.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:1494-1497. doi: 10.1109/EMBC.2018.8512455.

PMID:
30440675
40.

Triptolide as a novel agent in pancreatic cancer: the validation using patient derived pancreatic tumor cell line.

Kim ST, Kim SY, Lee J, Kim K, Park SH, Park YS, Lim HY, Kang WK, Park JO.

BMC Cancer. 2018 Nov 12;18(1):1103. doi: 10.1186/s12885-018-4995-0.

41.

Folate receptor-targeted liposomal nanocomplex for effective synergistic photothermal-chemotherapy of breast cancer in vivo.

Nguyen VD, Min HK, Kim CS, Han J, Park JO, Choi E.

Colloids Surf B Biointerfaces. 2019 Jan 1;173:539-548. doi: 10.1016/j.colsurfb.2018.10.013. Epub 2018 Oct 9.

PMID:
30343218
42.

Tumor regression grade as a clinically useful outcome predictor in patients with rectal cancer after preoperative chemoradiotherapy.

Huh JW, Kim HC, Kim SH, Park YA, Cho YB, Yun SH, Lee WY, Park HC, Choi DH, Park JO, Park YS, Chun HK.

Surgery. 2019 Mar;165(3):579-585. doi: 10.1016/j.surg.2018.08.026. Epub 2018 Oct 9.

PMID:
30314723
43.

Comparison of the 7th and the 8th AJCC Staging System for Non-metastatic D2-Resected Lymph Node-Positive Gastric Cancer Treated with Different Adjuvant Protocols.

Yu JI, Lim DH, Lee J, Kang WK, Park SH, Park JO, Park YS, Lim HY, Kim ST, Lee SJ, Kim S, Sohn TS, Lee JH, An JY, Choi MG, Bae JM, Yoo H, Kim K.

Cancer Res Treat. 2019 Jul;51(3):876-885. doi: 10.4143/crt.2018.401. Epub 2018 Oct 1.

44.

Antitumor activity of sorafenib plus CDK4/6 inhibitor in pancreatic patient derived cell with KRAS mutation.

Lee T, Kim K, Lee J, Park SH, Park YS, Lim HY, Kang WK, Park JO, Kim ST.

J Cancer. 2018 Sep 8;9(18):3394-3399. doi: 10.7150/jca.26068. eCollection 2018.

45.

Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy.

Lee JK, Liu Z, Sa JK, Shin S, Wang J, Bordyuh M, Cho HJ, Elliott O, Chu T, Choi SW, Rosenbloom DIS, Lee IH, Shin YJ, Kang HJ, Kim D, Kim SY, Sim MH, Kim J, Lee T, Seo YJ, Shin H, Lee M, Kim SH, Kwon YJ, Oh JW, Song M, Kim M, Kong DS, Choi JW, Seol HJ, Lee JI, Kim ST, Park JO, Kim KM, Song SY, Lee JW, Kim HC, Lee JE, Choi MG, Seo SW, Shim YM, Zo JI, Jeong BC, Yoon Y, Ryu GH, Kim NKD, Bae JS, Park WY, Lee J, Verhaak RGW, Iavarone A, Lee J, Rabadan R, Nam DH.

Nat Genet. 2018 Oct;50(10):1399-1411. doi: 10.1038/s41588-018-0209-6. Epub 2018 Sep 27.

PMID:
30262818
46.

Laboratory Investigation of Trends in Bacterial Pneumonia in Cheonan, Korea, from January 2008 to September 2017.

Yook YS, Jeon JS, Park JO, Kim JK.

J Microbiol Biotechnol. 2018 Oct 28;28(10):1730-1735. doi: 10.4014/jmb.1804.04004.

47.

Real-time microrobot posture recognition via biplane X-ray imaging system for external electromagnetic actuation.

Nguyen PB, Kang B, Bappy DM, Choi E, Park S, Ko SY, Park JO, Kim CS.

Int J Comput Assist Radiol Surg. 2018 Nov;13(11):1843-1852. doi: 10.1007/s11548-018-1846-z. Epub 2018 Aug 20.

PMID:
30128951
48.

Pemetrexed Monotherapy as Salvage Treatment in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy: A Phase II Single-arm Prospective Trial.

Lim SW, Lee S, Lee J, Park SH, Park JO, Park YS, Lim HY, Kang WK, Kim ST.

J Cancer. 2018 Jul 30;9(16):2910-2915. doi: 10.7150/jca.24948. eCollection 2018.

49.

E2F1 Mediates the Retinoic Acid-Induced Transcription of Tshz1 during Neuronal Differentiation in a Cell Division-Dependent Manner.

Park JH, Rhee K.

Mol Cell Biol. 2018 Oct 15;38(21). pii: e00217-18. doi: 10.1128/MCB.00217-18. Print 2018 Nov 1.

50.

Geometric Parameter Calibration for a Cable-Driven Parallel Robot Based on a Single One-Dimensional Laser Distance Sensor Measurement and Experimental Modeling.

Jin X, Jung J, Ko SY, Choi E, Park JO, Kim CS.

Sensors (Basel). 2018 Jul 23;18(7). pii: E2392. doi: 10.3390/s18072392.

Supplemental Content

Loading ...
Support Center